This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the ...

A trial tested an enhanced recovery after surgery (ERAS) protocol in patients who underwent ambulatory transurethral resection (TURBT) of bladder cancer.

Investigators reported results from the first randomized controlled trial of office-based laser photocoagulation to standard TURBT for low-grade Ta bladder tumors.

A bladder infection is inflammation or irritation of the bladder, typically caused by bacteria. Your doctor may also refer to this as cystitis or a urinary tract infection (UTI) in your bladder. This ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

Verana Health(R) , a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has introduced new urologic-oncology datasets to support ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

Dr. Rachel Sosland, a board-certified urologist at Urology Austin, joined Studio 512 Co-Host Stephanie Gilbert to talk about common bladder control problems that affect millions of men and women in ...

ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...

Erlanger Urology will host a Bladder Cancer Support Group on the third Wednesday of each month, beginning August 20, from 3 to 4 p.m. in the Erlanger Medical Mall POB Conference Room, located on the ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small ...